Indication Segment Analysis: Degenerative Sacroiliitis (Largest Segment) vs Trauma (Fastest-Growing Segment)

Degenerative sacroiliitis represented the largest share of 40.92% in 2026 in the sacroiliac joint fusion market, reflecting the established need for intervention among patients experiencing persistent pain and functional limitations associated with degeneration of the sacroiliac joint. Increasing recognition of sacroiliac joint dysfunction as a source of chronic pain is supporting diagnosis and treatment demand. The availability of minimally invasive fusion approaches and growing clinical familiarity with procedures intended to stabilize the joint are further reinforcing adoption. In addition, greater attention to effective management of chronic musculoskeletal pain is sustaining the segment's leading position.

Trauma is emerging as the fastest-growing indication as greater awareness of sacroiliac joint injuries and the need for structural stabilization encourage the use of fusion procedures in appropriate cases. Traumatic injuries can create significant instability and pain, increasing demand for interventions that restore joint stability and support functional recovery. Improvements in minimally invasive surgical techniques and imaging-guided procedures are helping physicians address complex traumatic cases with greater procedural precision. These developments, combined with increasing focus on effective recovery following musculoskeletal injuries, are supporting stronger adoption within the trauma indication.

Treatment Type Segment Analysis: Surgery (Largest Segment) vs RF Ablation (Fastest-Growing Segment)

Surgery held the largest share in 2026 in the sacroiliac joint fusion market, supported by its established role in providing structural stabilization for patients with persistent sacroiliac joint dysfunction. Surgical approaches can directly address joint instability and are particularly relevant for patients whose symptoms remain unresolved through conservative management. Continued advances in minimally invasive techniques, improved procedural precision, and greater physician familiarity with sacroiliac joint interventions are supporting the use of surgical treatment. Growing efforts to improve functional outcomes and manage chronic pain effectively are also sustaining demand for operative approaches.

RF ablation is advancing at the fastest rate as physicians and patients increasingly seek minimally invasive options for managing sacroiliac joint-related pain. The technique uses targeted radiofrequency energy to disrupt pain-producing nerve pathways, offering an alternative for patients who may not require or prefer fusion surgery. Its less invasive nature, potential for outpatient treatment, and limited procedural burden are supporting increasing interest. As pain-management strategies continue to evolve toward targeted interventions and earlier consideration of minimally invasive therapies, RF ablation is gaining momentum within the treatment landscape.